Mechanism of anti-TNF therapy in inflammatory bowel disease


19Jan2018 11:00 - 12:00

PhD defence ceremony

TNF is a cell signaling protein that plays a significant role in inflammatory bowel disease (IBS). Alon Levin investigates the mechanism of action of therapy that uses TNF inhibitors to treat IBS. The aim is to confirm the in vitro findings in vivo mouse models of IBS and to develop methods to enhance the therapeutic effect of anti-TNF.

A.D. Levin: Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease. Towards improving Efficacy of Anti-TNF Therapy.


Prof. G.R. van den Brink

Prof. G.R.A.M. D'Haens


Dr M.E. Wildenberg



This event is open to the public.

Published by  University of Amsterdam